SEC
Fundamental Analysis
191 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APPAppLovin Corp | 94.5 | 100 | 100 | 91 | +70.86% | +105.9% | n/a | +77.12% | -2.28% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| APPFAPPFOLIO INC | 92 | 46.6 | 53.3 | 83 | +27.22% | +38.37% | n/a | +28.1% | -3.24% | 0% | 0 | n/a | n/a | ROIC expansion, Net debt reduction, Share count reduction, High quality compounder2 warnings |
| AAPLApple Inc. | 76 | 55.7 | 67.1 | 100 | +15.7% | +104.65% | +41.27% | +2.41% | -2.27% | 0.32% | 15 | 12.59% | 39.31x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage1 warning |
| ANABANAPTYSBIO, INC | 88 | 100 | 100 | 85 | +195.06% | n/a | n/a | +55.62% | -0.7% | 0% | 0 | n/a | n/a | Operating leverage, Share count reduction |
| APHAMPHENOL CORP /DE/ | 84.4 | 80.8 | 80.8 | 86 | +79.58% | +58.34% | n/a | +6.08% | +1.82% | 0.36% | 22 | 20.14% | 22.25x | Gross margin expansion, Operating leverage, Net debt reduction, Strong operating leverage |
| TPRTAPESTRY, INC. | 70.7 | 65.8 | 79.5 | 100 | +6.09% | +50.26% | +0.37% | n/a | -7.38% | 1.41% | 18 | 21.35% | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| TVTXTravere Therapeutics, Inc. | 83.2 | 100 | 100 | 84 | +139.92% | n/a | n/a | +659.55% | +5.8% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| AMATAPPLIED MATERIALS INC /DE | 68.8 | 56.1 | 53.5 | 100 | +13.18% | +38.73% | +16.61% | -0.13% | -1.48% | 0.37% | 22 | 16.59% | 47.22x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction, Share count reduction, Strong operating leverage |
| INTAIntapp, Inc. | 68.5 | 53.7 | 42.9 | 100 | +34.52% | -18.45% | +192.53% | +36.51% | +0.97% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, FCF growth2 warnings |
| BXCAPBOX INC | 77.7 | 62 | 62 | 87 | +12.45% | n/a | n/a | +11.81% | -6.61% | 0.63% | 1 | n/a | 2,671.14x | Gross margin expansion, Operating leverage, Share count reduction, Strong operating leverage |
| NSSCNAPCO SECURITY TECHNOLOGIES, INC | 73.3 | 11 | 28.2 | 91 | +3.66% | +30.08% | n/a | +8.43% | -2.95% | 1.69% | 4 | 47.26% | n/a | Gross margin expansion, ROIC expansion, Net debt reduction, Share count reduction1 warning |
| AITAPPLIED INDUSTRIAL TECHNOLOGIES INC | 65.6 | 50.9 | 54.5 | 100 | +8.76% | +19.45% | +7.95% | +1.87% | -3.28% | 0.58% | 40 | 18.05% | 32.71x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| HALOHALOZYME THERAPEUTICS, INC. | 73.9 | 76.8 | 76.8 | 86 | +56.56% | +36.7% | n/a | +16.52% | -4.29% | 0% | 0 | n/a | 18.49x | Operating leverage, Share count reduction, Strong operating leverage |
| ALDSAPPlife Digital Solutions Inc | 72.9 | 100 | 100 | 84 | +23,872.29% | n/a | n/a | +5,806.57% | n/a | 0% | 0 | n/a | n/a | Operating leverage1 warning |
| TGTXTG THERAPEUTICS, INC. | 65.9 | 100 | 90.1 | 91 | +118.95% | +13.82% | n/a | +4,356.2% | -3.37% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Share count reduction, Strong operating leverage1 warning |
| NTAPNetApp, Inc. | 65.8 | 61 | 76.6 | 91 | +8.63% | +221.37% | n/a | n/a | -3.85% | 0.92% | 14 | 32.37% | 36.29x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage1 warning |
| CARTMaplebear Inc. | 71.1 | 63.1 | 69.3 | 83 | +15.42% | +21.23% | n/a | n/a | -10.19% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage1 warning |
| APPNAPPIAN CORP | 64.9 | 100 | 100 | 91 | +23.72% | -0.21% | n/a | +28.52% | -1.62% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction |
| CFORCapForce Inc. | 79.4 | n/a | n/a | 73 | +5,932.37% | +97.04% | n/a | +782.29% | +89.12% | 0% | 0 | n/a | 1.12x | n/a3 warnings |
| GAPGAP INC | 67.2 | 70.3 | 70.3 | 87 | +2.88% | +46.14% | n/a | +14.56% | -5.24% | 3.02% | 41 | 30.27% | 6.31x | Gross margin expansion, Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage |
| ADAPYAdaptimmune Therapeutics PLC | 75.2 | 100 | 100 | 76 | +189.21% | n/a | n/a | +2,732.09% | +9.18% | 0% | 0 | n/a | n/a | Operating leverage1 warning |
| APGAPi Group Corp | 61.8 | 52.3 | 52.6 | 91 | +20.87% | +7.14% | n/a | +4.31% | +4.67% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| VCTRVictory Capital Holdings, Inc. | 59.1 | 8.5 | 26.2 | 91 | +74.38% | +16.05% | n/a | -8.31% | -2.99% | 1.75% | 8 | 47.56% | n/a | ROIC expansion, Net debt reduction, Share count reduction2 warnings |
| FHTXFoghorn Therapeutics Inc. | 68.2 | 100 | 100 | 78 | +36.39% | n/a | n/a | +1,020.44% | +12.38% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction2 warnings |
| PLXProtalix BioTherapeutics, Inc. | 67.8 | 100 | 100 | 77 | +92.42% | +70.46% | n/a | +158.55% | +7.76% | 0% | 0 | n/a | 9.09x | Gross margin expansion, Operating leverage, Net debt reduction2 warnings |
1-25 of 191